Personalized Medicine
Genomic studies combined with individual testing enables us to determine a patient’s susceptibility to disease, predict how they will respond to a particular drug, and match them with the right therapeutics. Indeed, this new comparative science of personalized medicine has the potential to eliminate unnecessary treatments, reduce the incidence of adverse reactions, increase drug efficacy, and, ultimately, improve patient outcomes and reduce system costs. In their latest report on PM, PricewaterhouseCoopers termed it a "disruptive innovation" for life sciences and estimates that the market will grow to $450B by 2015.